About the Society
Uniting the Global KLF/Sp Research Community
Born from nearly two decades of informal scientific exchange, the International Society for KLF Research is the formal home for investigators advancing the biology of Krüppel-like Factors worldwide.
Steering Committee
2025–2027
Konstantinos Drosatos
President
University of Cincinnati, USA
Jonathan Katz
Vice-President
University of Pennsylvania, USA
Laura Zelarayan
General Secretary
Justus-Liebig-Universität Giessen, Germany
Gwen Lomberk
Treasurer
Mayo Clinic Arizona, USA
Kate Quinlan
Councilor
UNSW Sydney, Australia
Ceshi Chen
Councilor
Kunming Medical University, China
Ichiro Manabe
Councilor
Chiba University, Japan
Advisory Board
Ryozo Nagai (Chair)
Chief Medical Officer of the Imperial Household of Japan
Mukesh Jain
Brown University, USA
Jim Bieker
Mount Sinai School of Medicine, USA
Raul Urrutia
Mayo Clinic Arizona, USA
Merlin Crossley
UNSW Sydney, Australia
Andrew Perkins
Monash University, Australia
Sarah Millar
Mount Sinai School of Medicine, USA
Background
Our History
The International Society for KLF Research grew out of a scientific community that had been meeting for nearly two decades before it took formal shape. In 2007, Ryozo Nagai — then Professor and Chairman of Cardiovascular Medicine at the University of Tokyo — proposed, in conversation with Scott Friedman of Mount Sinai and Masato Kasuga of Kobe University, that investigators working on the Krüppel-like factors should have a forum of their own, since the field had grown substantially without ever gathering in one room.
The 1st International Symposium on the Biology of the Krüppel-like Factors convened at the University of Tokyo on March 6–7, 2008. Subsequent meetings were held in the United States (2010, 2012, 2014, 2016), Japan (2018), and Greece (2024). In 2026 the community formalized itself: the Society was incorporated in Pennsylvania and recognized as a tax-exempt organization under section 501(c)(3) of the U.S. Internal Revenue Code, inaugurated at the KLF/SP meeting in Gießen, Germany, with Professor Nagai as Honorary President.
Key Milestones
Molecular Biology
The KLFs
KLF/SP proteins constitute a single family of zinc finger-containing transcription factors that exhibit homology to the Drosophila gap gene product, Krüppel. There are at least 18 KLFs and 9 Sp proteins, with a multitude of important functions including regulation of proliferation, differentiation, inflammation/immunity, metabolism, and carcinogenesis. The family’s name originates with its founding member. Erythroid Krüppel-like factor (EKLF) was the first of these proteins to be identified, and the term “Krüppel-like factor” was coined by a comprehensive study performed by the group of James J. Bieker (1993). That first report directly influenced the isolation of many of the KLFs that followed, and EKLF has since been regarded as the founding member of the family — the reason the HUGO Gene Nomenclature Committee designated it KLF1. EKLF/KLF1 is now recognized as a master regulator of all aspects of erythropoiesis.
Dysregulation of KLF/SP-mediated pathways contributes to pathological states such as obesity, cancer, and inflammatory conditions. Recent studies indicate that many of these transcription factors have the ability to reprogram somatic cells to inducible pluripotent stem (iPS) cells, and to maintain the pluripotent state of embryonic stem cells — with several members able to substitute for one another in establishing and/or maintaining pluripotency. KLF4 has been recognized as one of the four factors whose forced expression converts human somatic cells into induced pluripotent stem cells. This finding overturned the view of differentiation as irreversible and brought Shinya Yamanaka a share of the 2012 Nobel Prize in Physiology or Medicine.
Molecular insights derived from zinc finger–DNA interactions, most thoroughly validated from work on Sp/KLF proteins, have given rise to a rapidly growing area of research: gene-editing by artificial KLF-like zinc finger proteins that allow for in vivo gene mutation, mutation repair, deletions, insertions, and other forms of engineering for both research and medical practice.
Proliferation & Differentiation
KLF/SP factors are master regulators of cell cycle progression and lineage commitment across virtually every tissue type.
Stem Cells & Reprogramming
KLF4 is a core Yamanaka reprogramming factor; multiple KLFs govern pluripotency and the maintenance of embryonic stem cell identity.
Inflammation & Immunity
KLF2 and KLF4 direct lymphocyte trafficking and macrophage polarization in both innate and adaptive immune responses.
Metabolism
KLF15 and KLF11 control metabolic gene programs in the liver, adipose tissue, and skeletal muscle, with links to obesity and diabetes.
Cancer
Sp1 and multiple KLFs are dysregulated in cancer, making the family an attractive set of therapeutic targets in oncology.
Gene Editing
Artificial KLF-like zinc finger proteins enable in vivo gene mutation, repair, deletion, and insertion — a transformational tool for research and medicine.
Become a Member
Join hundreds of researchers worldwide who are advancing the science of KLF and Sp transcription factors.